Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Johan Richter

Name: EURO-SKI trial: stopping tyrosine kinase inhibitors in a very large cohort of European CML patients
Uploaded: 2016-06-09T00:00:00.000Z
Duration: 5 min 26 s
Description: Press brief by Johan Richter, MD, PhD of the Skåne University Hospital Lund, Lund, Sweden, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.

Sorry, no posts matched your criteria.

Johan Richter

Cookie settings